ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Japan's AnGes aims to release coronavirus vaccine by end of year 

Clinical trial to begin in July as firm races to catch up with rivals in US and China

An AnGes researcher works in a company lab developing a DNA vaccine for the coronavirus on May 16. The company was able to move up the start of clinical trials from September to July.  (Nikkei Montage/ Source photo by Kyodo and AnGes)

TOKYO -- Japanese biotech venture AnGes is set to begin a clinical trial of a coronavirus vaccine in July, Nikkei learned Monday, raising hopes that the medication could secure government approval by the end of the year. 

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more